Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection

Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice

(2016) Nghiem B. Ha et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

HBV infection is associated with greater mortality in hospitalised patients compared to HCV infection or alcoholic liver disease

(2015) R. Rajbhandari et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study

(2015) J. Ahn et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection

(2015) T.-C. Tseng et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance

(2015) Gi-Ae Kim et al.   JOURNAL OF HEPATOLOGY

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

(2015) Aparna Schweitzer et al.   LANCET

Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤40 IU/L and significant hepatic fibrosis

(2014) D. T. Chao et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Māori: results from a 28-year follow-up study

(2014) Tien Huey Lim et al.   GUT

Loss of HBsAg and antiviral treatment: from basics to clinical significance

(2014) Yuecheng Yu et al.   Hepatology International

Risk of hepatocellular carcinoma in cirrhotic hepatitis B virus patients during nucleoside/nucleotide analog therapy

(2014) Etsuro Orito et al.   HEPATOLOGY RESEARCH

Long-term outcome in Caucasian patients with chronic hepatitis B virus infection after HBsAg seroclearance

(2014) Eugenia Lauret et al.   LIVER INTERNATIONAL

Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review

(2013) Long H. Nguyen et al.   Clinical Gastroenterology and Hepatology

Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels

(2013) Milan J. Sonneveld et al.   HEPATOLOGY

Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up

(2013) Mariko Kobayashi et al.   JOURNAL OF GASTROENTEROLOGY

Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: A clinical study

(2013) Peng Ruan et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Long-term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide-naïve chronic hepatitis B patients

(2013) T. Hara et al.   JOURNAL OF VIRAL HEPATITIS

Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice

(2012) Anne Liu et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance

(2012) Wai-Kay Seto et al.   HEPATOLOGY

High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy

(2012) Kevin T. Chaung et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice

(2012) Brian Lin et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection

(2012) Jessica Liu et al.   JOURNAL OF HEPATOLOGY

Predictors of HBsAg Seroclearance in HBeAg-Negative Chronic Hepatitis B Patients

(2011) Min-Sun Kwak et al.   DIGESTION

Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B

(2011) Nghiem B. Ha et al.   DIGESTIVE DISEASES AND SCIENCES

Incidence and Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance: A Community-Based Follow-Up Study

(2010) Jessica Liu et al.   GASTROENTEROLOGY

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus DNA and Normal Alanine Aminotransferase Levels

(2009) Mindie H Nguyen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a

(2009) Patrick Marcellin et al.   GASTROENTEROLOGY

Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus

(2009) Josephine Simonetti et al.   HEPATOLOGY

Significant Prevalence of Histologic Disease in Patients With Chronic Hepatitis B and Mildly Elevated Serum Alanine Aminotransferase Levels

(2008) Philip S.Y. Tsang et al.   Clinical Gastroenterology and Hepatology

Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b

(2008) Erik H.C.J. Buster et al.   GASTROENTEROLOGY

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

(2008) Patrick Marcellin et al.   NEW ENGLAND JOURNAL OF MEDICINE